Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
Authors
Keywords
-
Journal
Pharmaceutics
Volume 11, Issue 8, Pages 365
Publisher
MDPI AG
Online
2019-07-31
DOI
10.3390/pharmaceutics11080365
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ocular Biodistribution of 89Zr-Bevacizumab in New Zealand Rabbits Determined Using PET/MRI: A Feasibility Study
- (2019) Xiaoyuan Liu et al. Iranian Journal of Radiology
- The gap between the need for novel retinal drug delivery methods, technologies in R&D phase, and approved ocular drug delivery technologies
- (2019) Ron Neumann et al. DRUG DISCOVERY TODAY
- How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview
- (2019) Theodoros Empeslidis et al. ADVANCES IN THERAPY
- Use of Bevacizumab and Ranibizumab for Wet Age-Related Macular Degeneration: Influence of CATT Results and Introduction of Aflibercept
- (2019) Suzann Pershing et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- PHARMACOKINETIC STUDY OF INTRAVITREAL AFLIBERCEPT IN HUMANS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2019) Diana V. Do et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Expression, activity and pharmacokinetic impact of ocular transporters
- (2018) Kati-Sisko Vellonen et al. ADVANCED DRUG DELIVERY REVIEWS
- The Treat-and-Extend Injection Regimen Versus Alternate Dosing Strategies in Age-related Macular Degeneration: A Systematic Review and Meta-analysis
- (2018) Mali Okada et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Development and validation of a novel semi-homogenous clinical assay for quantitation of Ranibizumab in human serum
- (2018) John Lowe et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Formulation Stabilization and Disaggregation of Bevacizumab, Ranibizumab and Aflibercept in Dilute Solutions
- (2018) Steven A. Giannos et al. PHARMACEUTICAL RESEARCH
- Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes
- (2017) Magdalena Edington et al. Expert Opinion on Drug Metabolism & Toxicology
- Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)
- (2017) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGICA
- Pharmacokinetic aspects of retinal drug delivery
- (2017) Eva M. del Amo et al. PROGRESS IN RETINAL AND EYE RESEARCH
- SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
- (2017) Robert L. Avery et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Recent developments in age-related macular degeneration: a review
- (2017) Waseem Al-Zamil et al. Clinical Interventions in Aging
- Systemic safety of intravitreal anti-vascular endothelial growth factor agents in age-related macular degeneration
- (2016) Vaidehi S. Dedania et al. CURRENT OPINION IN OPHTHALMOLOGY
- Bevacizumab clearance through the iridocorneal angle following intravitreal injection in a rat model
- (2016) Orly Gal-Or et al. EXPERIMENTAL EYE RESEARCH
- A model of the ocular pharmacokinetics involved in the therapy of neovascular age-related macular degeneration with ranibizumab
- (2015) Derek J Saunders et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- INFLUENCE OF OCULAR VOLUME AND LENS STATUS ON PHARMACOKINETICS AND DURATION OF ACTION OF INTRAVITREAL VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS
- (2015) Tim U. Krohne et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
- (2015) Alfredo García-Layana et al. Journal of Ophthalmology
- Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age-related macular degeneration: a randomised, prospective trial
- (2014) Claus Zehetner et al. ACTA OPHTHALMOLOGICA
- Serum and Plasma Vascular Endothelial Growth Factor Concentrations Before and After Intravitreal Injection of Aflibercept or Ranibizumab for Age-Related Macular Degeneration
- (2014) Xiying Wang et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
- (2014) Robert L Avery et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Comparison of the Release Profile and Pharmacokinetics of Intact and Fragmented Dexamethasone Intravitreal Implants in Rabbit Eyes
- (2014) Rahul Bhagat et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Pharmacokinetics of Ranibizumab after Intravitreal Administration in Patients with Retinal Vein Occlusion or Diabetic Macular Edema
- (2014) Yi Zhang et al. OPHTHALMOLOGY
- Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial
- (2014) H. A. Dakin et al. BMJ Open
- Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies
- (2014) Marie Thulliez et al. JAMA Ophthalmology
- Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF
- (2014) Michael W Stewart Expert Review of Clinical Pharmacology
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
- (2014) Wan Ling Wong et al. Lancet Global Health
- Long-term Stability of Vascular Endothelial Growth Factor Suppression Time Under Ranibizumab Treatment in Age-Related Macular Degeneration
- (2013) Philipp S. Muether et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema
- (2013) Claus Zehetner et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Serum Levels of Intravitreal Bevacizumab After Vitrectomy, Lensectomy and Non-Surgical Controls
- (2013) John B. Christoforidis et al. CURRENT EYE RESEARCH
- Intravitreal bevacizumab effects on VEGF levels in distant organs: an experimental study
- (2013) Erdem Dınc et al. Cutaneous and Ocular Toxicology
- Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes
- (2013) Elad Moisseiev et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo
- (2013) Qingguo Xu et al. JOURNAL OF CONTROLLED RELEASE
- Pharmacokinetics of Intravitreally Injected Bevacizumab in Vitrectomized Eyes
- (2013) Jeeyun Ahn et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Clinical Classification of Age-related Macular Degeneration
- (2013) Frederick L. Ferris et al. OPHTHALMOLOGY
- ANATOMIC AND PHARMACOKINETIC PROPERTIES OF INTRAVITREAL BEVACIZUMAB AND RANIBIZUMAB AFTER VITRECTOMY AND LENSECTOMY
- (2013) John B. Christoforidis et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
- (2012) Tim U. Krohne et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Pharmacokinetic Properties of Intravitreal I-124-Aflibercept in a Rabbit Model Using PET/CT
- (2012) John B. Christoforidis et al. CURRENT EYE RESEARCH
- Proteomic Analyses of the Vitreous Humour
- (2012) Martina Angi et al. MEDIATORS OF INFLAMMATION
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Simulating Intravitreal Injections in Anatomically Accurate Models for Rabbit, Monkey, and Human Eyes
- (2012) Paul J. Missel PHARMACEUTICAL RESEARCH
- Comparing protein VEGF inhibitors: In vitro biological studies
- (2011) Lanlan Yu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global estimates of visual impairment: 2010
- (2011) Donatella Pascolini et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Effective electrophoretic mobilities and charges of anti-VEGF proteins determined by capillary zone electrophoresis
- (2011) S. Kevin Li et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- INTRAOCULAR PHARMACOKINETICS AFTER A SINGLE INTRAVITREAL INJECTION OF 1.5 mg VERSUS 3.0 mg OF BEVACIZUMAB IN HUMANS
- (2011) Carsten H Meyer et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humans
- (2010) Carsten H. Meyer et al. ACTA OPHTHALMOLOGICA
- Development of a novel homogenous electrochemiluminescence assay for quantitation of ranibizumab in human serum
- (2010) John Lowe et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics
- (2010) Augustinus Laude et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Phase 1 Study of Aflibercept Administered Subcutaneously to Patients with Advanced Solid Tumors
- (2009) W. P. Tew et al. CLINICAL CANCER RESEARCH
- Diffusion characteristics of vitreous humour and saline solution follow the Stokes Einstein equation
- (2009) Svanborg Gisladottir et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans
- (2008) Tim U. Krohne et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Components of the fibrinolytic system in the vitreous body in patients with vitreoretinal disorders
- (2008) Jan Niklas Ulrich et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Physiology of vitreous surgery
- (2008) Einar Stefánsson GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Vitreous Levels of Bevacizumab and Vascular Endothelial Growth Factor-A in Patients with Choroidal Neovascularization
- (2008) Qi Zhu et al. OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now